Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis

Shihuan Cheng,1,* Zhihong Zhang,2,* Cong Hu,2,3 Na Xing,4 Yan Xia,5 Bo Pang3,6 1Department of Rehabilitation, The First Hospital of Jilin University, Changchun, Jilin 130021, People’s Republic of China; 2Centre for Reproductive Medicine, Centre for Prenatal Diagnosis, The First Hospital of...

Full description

Bibliographic Details
Main Authors: Cheng S, Zhang Z, Hu C, Xing N, Xia Y, Pang B
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/pristimerin-suppressed-breast-cancer-progression-via-mir-542-5pdub3-ax-peer-reviewed-article-OTT